A qualitative study to assess the perceived benefits and barriers to the pneumococcal vaccine in hospitalised older people

Vaccine

Volumn 27, Issue 28, 2009, Pages 3775-3779

  Ridda, I ^a   MacIntyre, C R ^a,b   Lindley, R I ^c  

^a NATIONAL CENTRE FOR IMMUNISATION RESEARCH AND SURVEILLANCE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Hospitalised patient; Older people; Patients acceptance of health care; Pneumococcal vaccine; Qualitative research

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADULT; AGED; AGED HOSPITAL PATIENT; ARTICLE; AUSTRALIA; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; ETHNICITY; FEMALE; HUMAN; INTERVIEW; KNOWLEDGE; MALE; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT SELECTION; PRIORITY JOURNAL; QUALITATIVE RESEARCH; REFUSAL TO PARTICIPATE; STREPTOCOCCUS PNEUMONIAE; TRUST; VACCINATION;

AGED; AGED, 80 AND OVER; AUSTRALIA; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES;

EID: 67349187949     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.03.075     Document Type: Article

References (33)

1. Andrews R.M., and Lester R.A. Improving pneumococcal vaccination coverage among older people in Victoria. Medical Journal of Australia 173 October (Suppl.) (2000) S45-S47
2. Forrest J.M., McIntyre P.B., and Burgess M.A. Pneumococcal disease in Australia. Communicable Diseases Intelligence 24 4 (2000) 89-92
3. Mulholland K. Strategies for the control of pneumococcal diseases. Vaccine 17 Suppl. 1 (1999) S79-S84
4. Dear KBG, Andrews RR, Holden J, Tatham DP. Vaccines for preventing pneumococcal infection in adults (Review). The Cochrane Library; 2006. Report No.: 4.
5. Moberley SA, Holden J, Tatham DP, Andrews R. Vaccines for preventing pneumococcal infection in adults. Cochrane Database of Systematic Reviews: CD000422 2008; (January 23 (1)).
6. Beriman R.F., Keller D.W., Phelan M.A., Sniadack D.H., Stephens D.S., Rimland D., et al. Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients. Archives of Internal Medicine 160 17 (2000) 2633-2638
7. Fedson D.S., and Breiman R.F. Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996. Clinical Infectious Diseases 26 5 (1998) 1117-1126
8. Andrews R.M. Assessment of vaccine coverage following the introduction of a publicly funded pneumococcal vaccine program for the elderly in Victoria, Australia. Vaccine 23 21 (2005) 2756-2761
9. Ridda I., MacIntyre R.C., Lindley R.I., McIntyre P.B., Sullivan J., Gilbert G., et al. Predictors of pneumococcal vaccination uptake in hospitalized patients aged 65 years and over shortly following the commencement of a publicly funded national pneumococcal vaccination program in Australia. Human Vaccines 3 3 (2007) 83-86
10. Andrews R.M., Counahan M.L., Hogg G.G., and McIntyre P.B. Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia. Vaccine 23 2 (2004) 132-138
11. Rixon G., March L., and Holt D.A. Immunisation practices of general practitioners in metropolitan Sydney. Australian Journal of Public Health 18 September (3) (1994) 258-260
12. Australian Bureau of Statistics (ABS). Immunisation Australia. ABS Catalogue [No. 4352.0, April 1995.]; 1995.
13. WHO. Global review of missed opportunities for immunisation. WHO Weekly Epidemiological Record 68 24 (1993) 164-166
14. Zimmerman R.K., Santibanez T.A., Fine M.J., Janosky J.E., Nolwalk M.P., Bardella I.J., et al. Barriers and facilitators of pneumococcal vaccination among the elderly. Vaccine 21 13-14 (2003) 1510-1517
15. Bovier P.A., Chamot E., Gallacchi M.B., and Loutan L. Importance of patients' perceptions and general practitioners' recommendations in understanding missed opportunities for immunisations in Swiss adults. Vaccine 19 32 (2001) 4760-4767
16. Mieczkowski T.A., and Wilson S.A. Adult pneumococcal vaccination: a review of physician and patient barriers. Vaccine 20 9-10 (2002) 1383-1392
17. Fedson D.S. Clinical practice and public policy for influenza and pneumococcal vaccination of the elderly. Clinics in Geriatric Medicine 8 1 (1992) 183-199
18. de Roux A., Schmole-Thoma B., Siber G.R., Hackell J.G., Kuhnke A., Ahlers N., et al. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory [erratum appears in Clin Infect Dis 2008 May 1;46(9):1488 Note: Schmoele-Thoma, B [corrected to Schmole-Thoma, B]]. Clinical Infectious Diseases 46 April 1 (7) (2008) 1015-1023
19. O'Brien K.L., Hochman M., and Goldblatt D. Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue? [Review] [79 refs]. The Lancet Infectious Diseases 7 September (9) (2007) 597-606
20. Ganguly R., and Cameron D. Factors affecting immunization rate in a cohort of elderly veterans: a retrospective pilot study of influenza vaccine compliance. Vaccine 7 5 (1989) 462-464
21. Glasser M.A. A study of the public's acceptance of the Salk vaccine program. American Journal of Public Health & the Nation's Health 48 2 (1958) 141-146
22. Polis M.A., Smith J.P., Sainer D., Brenneman M.N., and Kaslow R.A. Prospects for an emergency department-based adult immunization program. Archives of Internal Medicine 147 11 (2001)
23. Fedson D.S. Adult immunization. Summary of the National Vaccine Advisory Committee Report. JAMA 272 October 12 (14) (1994) 1133-1137
24. Metersky M.L., Mennone J.Z., and Fine J.M. Factors inhibiting use of the pneumococcal polysaccharide vaccine: a survey of Connecticut physicians. Connecticut Medicine 62 11 (1998) 649-654
25. Nichol K.L., Mac D.R., and Hauge M. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. Journal of General Internal Medicine 11 11 (1996) 673-677
26. Nicholson K.G., Wiselka M.J., and May A. Influenza vaccination of the elderly: perceptions and policies of general practitioners and outcome of the 1985-86 immunization programme in Trent, UK. Vaccine 5 4 (1987) 302-306
27. Zimmerman R.K. Lowering the age for routine influenza vaccination to 50 years: AAFP leads the nation in influenza vaccine policy. American Academy of Family Physicians. American Family Physician 60 November 1 (7) (1999) 2061-2070
28. The Department of Infrastructure Planning and Natural Resources. Health service profile. Population projection for SWAHS. Annual report. NSW Government. Accessed; 2005.
29. Ridda I., Lindley I.R., Gao Z., McIntyre P., and MacIntyre C.R. Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people. Vaccine August 14 (26) (2008) 5633-5640
30. Ament A., Baltussen R., Duru G., Riqaud-Bully C., de Graeve D., Ortqvist A., et al. Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries. Clinical Infectious Diseases 31 2 (2000) 444-450
31. Ament A., Fedson D.S., and Christie P. Pneumococcal vaccination and pneumonia: even a low level of clinical effectiveness is highly cost-effective. Clinical Infectious Diseases 33 12 (2001) 2078-2079
32. Ridda I., MacIntyre C.R., Lindley R., Gao Z., Sullivan J.S., Yuan F.F., et al. Immunological responses to pneumococcal vaccine in frail older people. Vaccine 27 March 4 (10) (2009) 1628-1636
33. Scheurer D.B., Cawley P.J., Brown S.B., and Heffner J.E. Overcoming barriers to pneumococcal vaccination in patients with pneumonia. American Journal of Medical Quality 21 January (1) (2006) 18-29